AFM investigation on Ox-LDL-induced changes in cell spreading and cell-surface adhesion property of endothelial cells

Scanning

Volumn 35, Issue 2, 2013, Pages 119-126

  Shao, Wenxiang ^a   Jin, Hua ^b   Huang, Jie ^a   Qiu, Bin ^a   Xia, Ruihua ^b   Deng, Zeyuan ^a   Cai, Jiye ^b   Chen, Yong ^a  

^a NANCHANG UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

adhesive force; atherosclerosis; atomic force microscopy (AFM); cell spreading; human umbilical vein endothelial cells (HUVECs); oxidized low density lipoprotein (Ox LDL)

Indexed keywords

ADHESIVE FORCE; ATHEROSCLEROSIS; CELL SPREADING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; OXIDIZED LOW-DENSITY LIPOPROTEINS;

ADHESION; ATOMIC FORCE MICROSCOPY; BIOMECHANICS; CYTOLOGY; DENSITY (SPECIFIC GRAVITY); DISEASES; LIPOPROTEINS;

ENDOTHELIAL CELLS;

OXIDIZED LOW DENSITY LIPOPROTEIN;

APOPTOSIS; ARTICLE; ATHEROGENESIS; ATOMIC FORCE MICROSCOPY; BLOOD CELL; CELL ADHESION; CELL DEATH; CELL NUCLEUS; CELL SPREADING; CELL SURFACE; CELL VIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID STORAGE; PRIORITY JOURNAL; STATIC ELECTRICITY; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL ADHESION; CELL SURVIVAL; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, CONFOCAL;

EID: 84876286524     PISSN: 01610457     EISSN: 19328745     Source Type: Journal    
DOI: 10.1002/sca.21040     Document Type: Article

References (30)

1. Chouinard JA, Grenier G, Khalil A, Vermette P,. 2008. Oxidized-LDL induce morphological changes and increase stiffness of endothelial cells. Exp Cell Res 314: 3007-3016.
2. Chtcheglova LA, Wildling L, Waschke J, Drenckhahn D, Hinterdorfer P,. 2010. AFM functional imaging on vascular endothelial cells. J Mol Recognit 23: 589-596.
3. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, Pastorino AM, LoCascio V,. 1997. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radical Bio Med 22: 117-127.
4. Cote C, Pibarot P, Despres JP, Mohty D, Cartier A, Arsenault BJ, Couture C, Mathieu P,. 2008. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis. Heart 94: 1175-1180.
5. Fraley AE, Tsimikas S,. 2006. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 17: 502-509.
6. Galle J, Heinloth A, Wanner C, Heermeier K,. 2001. Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress. Kidney Int 59: S120-S123.
7. Grassi D, Desideri G, Ferri C,. 2011. Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis. Curr Pharm Biotechnol 12: 1343-1353.
8. Greilberger J, Schmut O, Jurgens G,. 1997. In vitro interactions of oxidatively modified LDL with type I, II, III, IV and V collagen, laminin, fibronectin, and poly-D-lysine. Arterioscl Throm Vas 17: 2721-2728.
9. Heinecke JW,. 1998. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141: 1-15.
10. Itabe H, Ueda M,. 2007. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J Atheroscler Thromb 14: 1-11.
11. Jin H, Zhong X, Wang ZY, Huang X, Ye HY, Ma SY, Chen Y, Cai JY,. 2011. Sonodynamic effects of hematoporphyrin monomethyl ether on CNE-2 cells detected by atomic force microscopy. J Cell Biochem 112: 169-178.
12. Khan BV, Parthasarathy SS, Alexander RW, Medford RM,. 1995. Modified low-density-lipoprotein and its constituents augment cytokine-activated vascular cell-adhesion molecule-1 gene-expression in human vascular endothelial-cells. J Clin Invest 95: 1262-1270.
13. Kitano S, Higashimoto Y, Harada S, Sano M, Kurata T, Yamaguchi Y, Kunitomo M, Haginaka J, Yamagishi S,. 2010. An improved anion-exchange high-performance liquid chromatography method for measuring oxidized form of LDLs in human plasma. Ann Clin Biochem 47: 460-466.
14. Kyaw T, Tipping P, Toh BH, Bobik A,. 2011. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr Opin Lipidol 22: 373-379.
15. Lahoute C, Herbin O, Mallat Z, Tedgui A,. 2011. Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol 8: 348-358.
16. Libby P, Ridker PM, Hansson GK,. 2011. Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317-325.
17. Mathur AB, Truskey GA, Reichert WM,. 2000. Atomic force and total internal reflection fluorescence microscopy for the study of force transmission in endothelial cells. Biophys J 78: 1725-1735.
18. Muller DJ, Dufrene YF,. 2011. Atomic force microscopy: a nanoscopic window on the cell surface. Trends Cell Biol 21: 461-469.
19. Parthasarathy S, Steinberg D, Witztum JL,. 1992. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Ann Rev Med 43: 219-225.
20. Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, Punzi L, Doria A,. 2011. Atherosclerosis in psoriatic arthritis. Autoimmun Rev 10: 773-778.
21. Sata M, Walsh K,. 1998a. Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem 273: 33103-33106.
22. Sata M, Walsh K,. 1998b. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J Clin Invest 102: 1682-1689.
23. Sato H, Kataoka N, Kajiya F, Katano M, Takigawa T, Masuda T,. 2004. Kinetic study on the elastic change of vascular endothelial cells on collagen matrices by atomic force microscopy. Colloids Surf B Biointerfaces 34: 141-146.
24. Seibold S, Schurle D, Heinloth A, Wolf G, Wagner M, Galle J,. 2004. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27 (Kip1) expression: role of RhoA. J Am Soc Nephrol 15: 3026-3034.
25. Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, Tramontana S, Perticone F, Naccarato P, Camici P, Picano E, Cortigiani L, Bevilacqua M, Milazzo L, Cusi D, Barlassina C, Sarzi-Puttini P, Turiel M,. 2010. From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9: 830-834.
26. Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, Nagai R, Invest C,. 2002. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 35: 347-353.
27. Tavridou A, Efthimiadis A, Efthimiadis I, Manolopoulos VG,. 2010. Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. Heart Vessels 25: 288-293.
28. Weber C, Noels H,. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422.
29. Yamashita H, Ehara S, Yoshiyama M, Naruko T, Haze K, Shirai N, Sugama Y, Ikura Y, Ohsawa M, Itabe H, Kataoka T, Kobayashi Y, Becker AE, Yoshikawa J, Ueda M,. 2007. Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina. Circ J 71: 681-687.
30. Zhang XH, Wojcikiewicz EP, Moy VT,. 2006. Dynamic adhesion of T lymphocytes to endothelial cells revealed by atomic force microscopy. Exp Biol Med 231: 1306-1312